QQ客服 官方微博 反馈留言

	SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment
	Abdel-Fatah, Tarek M. A.; Broom, Reuben J.; Lu, Jun; Moseley, Paul M.; Huang, Baiqu; Li, Lili; Liu, Suling; Chen, Longxin; Ma, Runlin Z.; Cao, Wenming
刊名	BRITISH JOURNAL OF CANCER
	2019
卷号	120期号:7
ISSN号	0007-0920
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3599190
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Abdel-Fatah, Tarek M. A.,Broom, Reuben J.,Lu, Jun,et al. SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment[J]. BRITISH JOURNAL OF CANCER,2019,120(7).
APA	Abdel-Fatah, Tarek M. A..,Broom, Reuben J..,Lu, Jun.,Moseley, Paul M..,Huang, Baiqu.,...&Liu, Dong-Xu.(2019).SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.BRITISH JOURNAL OF CANCER,120(7).
MLA	Abdel-Fatah, Tarek M. A.,et al."SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment".BRITISH JOURNAL OF CANCER 120.7(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。